OBODENCE Trademark

Trademark Overview


On Friday, January 5, 2024, a trademark application was filed for OBODENCE with the United States Patent and Trademark Office. The USPTO has given the OBODENCE trademark a serial number of 79389340. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 8, 2024. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The OBODENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; phar...
obodence

General Information


Serial Number79389340
Word MarkOBODENCE
Filing DateFriday, January 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; nutraceuticals for medical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, February 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 15, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 23, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, February 28, 2024APPLICATION FILING RECEIPT MAILED
Friday, June 7, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 18, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 8, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, July 28, 2024REFUSAL PROCESSED BY IB
Monday, July 8, 2024REFUSAL PROCESSED BY MPU